This licensing agreement grants Kappa Bioscience rights to combine OptiBiotix's LPLDL with Kappa's vitamin K2 product for cardiovascular health applications in 27 European countries, Russia, and Singapore. OptiBiotix formed its...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)